Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine

Susan A Nzenze1, Tinevimbo Shiri, Marta C Nunes

  • 1From the *Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases; †Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa; ‡Department of Global Health, Rollins School of Public Health; and §Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia; ¶MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; ‖Centre for Global Health Research, Umeå University, Umeå, Sweden; **INDEPTH Network, Accra, Ghana; and ††National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham, South Africa.

Insights

Routine infant pneumococcal conjugate vaccine (PCV) immunization significantly reduced vaccine-type nasopharyngeal colonization in a South African community. This indirect effect was observed within two years, even in a high HIV prevalence setting.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Pneumococcal conjugate vaccine (PCV) immunization in children reduces nasopharyngeal carriage of vaccine-type *Streptococcus pneumoniae*.
  • The study investigated the impact of routine infant PCV immunization on pneumococcal colonization in a rural African community with a high prevalence of HIV.

Purpose of the Study:

  • To assess the effect of routine infant PCV immunization on the epidemiology of nasopharyngeal pneumococcal colonization.
  • To evaluate the indirect impact of PCV on different age groups and the prevalence of non-vaccine serotypes in a high HIV setting.

Main Methods:

  • Two cross-sectional surveys were conducted in a rural South African community before and after the introduction of 7-valent PCV (PCV7) in April 2009.
  • Nasopharyngeal swabs were collected from household members of randomly selected households with at least one child under two years old.
  • Swabs were cultured for *Streptococcus pneumoniae* and serotyped using the Quellung method.

Main Results:

  • Overall prevalence of vaccine serotype colonization decreased from 18.3% to 11.4% (P<0.0001) within two years of PCV7 introduction.
  • Significant reductions in vaccine serotype colonization were observed across all age groups, including children under 2 years (50% reduction), 6-12 year olds (34% reduction), and adults (64% reduction).
  • Prevalence of non-vaccine serotype colonization increased in young children (<2 years) but decreased significantly in adolescents and adults.

Conclusions:

  • Routine infant PCV7 immunization demonstrated an indirect protective effect against vaccine serotype colonization within two years in a high HIV prevalence setting.
  • The observed decline in non-vaccine serotype colonization among adolescents and adults suggests a potential lag in replacement colonization in these groups.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: